You’ve probably noticed that every time a crisis hits, the government throws a billion dollars at a problem and then pats itself on the back. But here’s the dirty secret: the easiest way to get $1 billion from the US government is to promise to make something America can’t.
Bloomberg just dropped a story that should make you furious. Almost $1 billion in federal grants later, the United States still cannot manufacture a single medical glove. Not one. The country that can project military power across every ocean, that built the internet, that landed robots on Mars — can’t make a thin piece of rubber you put on your hand.
And the real kicker? The money itself is the problem.
One commenter on the article nailed it: “How are these awards structured? Are they just grants? If so, doesn’t that create a perverse incentive to take the money even if you never intend to deliver the result?”
Bingo. We’ve created a system where the most profitable move is to apply for a grant, take the cash, and fail gracefully. No one goes to jail. No one loses their job. The company just pockets the money and says “sorry, market forces.” Meanwhile, the true cost of reshoring — the real labor, the real supply chains, the real chemistry — never gets addressed.
This isn’t a story about China. It’s a story about us. We’ve become experts at subsidizing failure, not building capacity. We throw money at symptoms, not systems. And then we wonder why our hospitals rely on gloves from Malaysia.
But there’s a deeper rot. The grants go to companies that have no experience in glove manufacturing. They hire consultants. They write reports. They build a factory that runs for a month, then shuts down because the raw material supply chain doesn’t exist. The government doesn’t check for competence — it checks for a good pitch.
So what should we do? Stop pretending that writing a check is the same as building a factory. If you want to make gloves, you don’t fund a moonshot — you fund 50 small, dirty, boring factories that already know how to make latex. You fix the tariff on raw rubber. You invest in vocational training, not another grant program.
But that’s hard. It’s unsexy. It doesn’t make headlines. And it certainly doesn’t earn anyone a speaking slot at Davos.
So we’ll keep spending billions on failure. And the next time a pandemic hits, we’ll be watching the same rerun — wondering why the world’s richest country can’t protect its own doctors.
FAQ
Q: Isn't it just cheaper to import gloves from Asia? Why should the US even try to make them?
A: Cheaper in the short term, yes. But that ignores the cost of supply chain fragility — look at the PPE shortages during COVID. The point isn't that domestic manufacturing should be cheaper; it's that we should be willing to pay a premium for resilience. But the current grant system doesn't build resilience; it builds a paper trail.
Q: What's the practical implication for a regular person?
A: The next time you need a medical glove — or a ventilator, or a mask — you're betting on a global supply chain that can be disrupted by a single factory fire in Malaysia. The US government's failure to create real manufacturing capacity means your safety depends on luck. That's not a system you can trust.
Q: Couldn't we just fix the grant system instead of giving up on it?
A: The contrarian view is that the entire grant approach is flawed. Grants reward proposals, not results. A better model would be a guaranteed purchase agreement: the government commits to buy a certain number of gloves at a fixed price, but only if the factory actually produces them. That shifts risk to the private sector and forces real investment. But that requires politicians to stop grandstanding and start negotiating contracts.